Singapore

Brief Singapore: Japan – Chinese Flu and more

In this briefing:

  1. Japan – Chinese Flu
  2. ESR Cayman Pre-IPO – A Giant in the Making

1. Japan – Chinese Flu

Sk2

By Konstantinos Venetis, Senior Economist

  • Japan skirts recession but near-term prospects remain weak
  • Deflationary headwinds to persist in H1, threatening business spending
  • Recovery likely in late 2019 as world trade finds a firmer footing

2. ESR Cayman Pre-IPO – A Giant in the Making

Revenue%20breakdown

ESR Cayman (ESR HK) aims to raise up to US$1.5bn in its planned Hong Kong listing, as per media reports. The company is backed by Warburg Pincus and counts APG, the Netherlands’ largest pension provider, as one of its main investors.

ESR operates an end-to-end model starting from development of the asset to divesting it to one of its private funds and/or REITs. It operates in China, Japan, South Korea, Australia, Singapore and India. AUM has grown rapidly over the past few years as the company has undertaken a number of acquisitions in the recent past. 

In this insight, I’ll touch upon the company’s business model and provide an overview of its operations. 

Get Straight to the Source on Smartkarma

Smartkarma supports the world’s leading investors with high-quality, timely, and actionable Insights. Subscribe now for unlimited access, or request a demo below.